Penumbra Inc., led by CEO Adam Elsesser, is pivoting to prioritize its core thrombectomy business as it lowers its 2024 sales forecast and announces significant layoffs. This strategic realignment is aimed at optimizing resources and addressing ongoing market challenges within the medtech sector.
https://zenopa.com/us/news/penumbra-refocuses-on-core-business-amid-layoffs-and-strategic-shifts-2/